FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2906596328> ?p ?o ?g. }

• W2906596328 endingPage "35" @default.
• W2906596328 startingPage "25" @default.
• W2906596328 abstract "The successful landmark discovery of mouse and human inducible pluripotential stem cells (iPSC’s) by Takahashi and Yamanaka in 2006 and 2007 has triggered a revolution in the potential generation of self-compatible cells for regenerative medicine, and further opened up a new avenue for “disease in dish” drug screening of self-target cells (Neofytou et al. 2015). The introduction of four ‘Yamanaka’ transcription factors through viral or other transfection of mature cells can induce pluripotency and acquired plasticity. These factors include transduction with octamer-binding transcription factor-4 (Oct-4), nanog homeobox (Nanog), sex-determining region Y-box-2 (Sox-2) and MYC protooncogene (cMyc). Such cells become iPSC’s (Takahashi and Yamanaka 2006). These reprogrammed cells exhibit increased telomerase activity and have a hypomethylated gene promotor region similar to embryonic stem cells (ESC’s). These milestone discoveries have generated immense hope that diseases such as diabetes could be treated and effectively cured by transplantation of self-compatible, personalized autologous stem cell transplantation of β-cells that release physiological insulin under glycemic control (Maehr et al. 2009; Park et al. 2008) (Fig. 1). Diabetes is a profligate disease of disordered glucose metabolism resulting from an absolute or relative deficiency of insulin, the consequences of which lead to immense socio-economic societal burden. While there are many different types of diabetes, the two major types (type 1 diabetes (T1DM) and type 2 diabetes (T2DM) are caused respectively by immune-mediated destruction (T1DM) or malfunctioning (T2DM) insulin-producing β-cells within the endocrine pancreas, the islets of Langerhans (Atkinson et al. 2011; Holman et al. 2015; You and Henneberg 2016). Almost 425 million people are affected by the global burden of diabetes, and this is predicted to increase by 48% (629 million) by 2045 (International Diabetes Federation Atlas 8th Ed 2018). Whole pancreas or islet cell transplantation offer an effective alternative to injected insulin, but both require lifelong potent immunosuppression to control both allo-and autoimmunity. Whole pancreas transplantation involves invasive complex surgery and is associated with greater morbidity and occasional mortality, while islet transplantation involves a minimally invasive intraportal hepatic infusion. Generally, whole pancreas transplantation provides greater metabolic reserve, but this may be matched by cumulative multiple islet infusions to achieve insulin independence. An additional challenge of islet transplantation is progressive loss of complete insulin independence over time, which may be multifactorial, the dominant factor however being ineffective control of autoimmunity. Both whole pancreas and islet transplantation are restricted to patients at risk of severe hypoglycemia that cannot be stabilized by alternate means, or in recipients that are already immunosuppressed in order to sustain a kidney or other solid organ transplant. The risks of chronic immunosuppression and the scarcity of human organ donors mean that both of these transplantation therapies cannot presently be extended to the broader diabetic population (Shapiro 2011; Shapiro et al. 2006). Recent progress in xenotransplantation of multiple knock-out ‘humanized’ pig islets could offer one potential solution, perhaps aided by clustered regularly interspaced short palindromic repeats/CRISPR associated-9 (CRISPR/Cas-9) gene editing approaches, but this remains to be proven in practice. Human stem cell derived new β-cell products could effectively address the global supply challenge for broad application across all forms of diabetes, but recurrent autoimmunity may still remain an insurmountable challenge. Considerable progress in the generation of human stem cell derived SC-β cells from ESC, iPS and other adult cell sources such as mesenchymal stem cells (MSCs) offer huge hope that a personalized, ‘syngeneic’ cell could be transplanted without risk of alloimmunity, thereby securing sufficient supply to meet future global demand (Cito et al. 2018)." @default.
• W2906596328 created "2019-01-01" @default.
• W2906596328 creator A5015316572 @default.
• W2906596328 creator A5067408895 @default.
• W2906596328 date "2018-01-01" @default.
• W2906596328 modified "2023-10-11" @default.
• W2906596328 title "Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead" @default.
• W2906596328 cites W1551630433 @default.
• W2906596328 cites W1899371747 @default.
• W2906596328 cites W1963637882 @default.
• W2906596328 cites W1970728400 @default.
• W2906596328 cites W1973424799 @default.
• W2906596328 cites W1979001502 @default.
• W2906596328 cites W1979457164 @default.
• W2906596328 cites W2006919788 @default.
• W2906596328 cites W2032321077 @default.
• W2906596328 cites W2032472678 @default.
• W2906596328 cites W2034540804 @default.
• W2906596328 cites W2051830265 @default.
• W2906596328 cites W2054361177 @default.
• W2906596328 cites W2092504606 @default.
• W2906596328 cites W2102369007 @default.
• W2906596328 cites W2120767666 @default.
• W2906596328 cites W2125987139 @default.
• W2906596328 cites W2135149410 @default.
• W2906596328 cites W2138726422 @default.
• W2906596328 cites W2157645703 @default.
• W2906596328 cites W2166837094 @default.
• W2906596328 cites W2225320923 @default.
• W2906596328 cites W2288809108 @default.
• W2906596328 cites W2330164386 @default.
• W2906596328 cites W2381312419 @default.
• W2906596328 cites W2425256690 @default.
• W2906596328 cites W24335825 @default.
• W2906596328 cites W2476437553 @default.
• W2906596328 cites W2506729364 @default.
• W2906596328 cites W2608182982 @default.
• W2906596328 cites W2621794998 @default.
• W2906596328 cites W2771103086 @default.
• W2906596328 cites W2790265474 @default.
• W2906596328 cites W2790489176 @default.
• W2906596328 cites W2794156263 @default.
• W2906596328 cites W2794778097 @default.
• W2906596328 cites W2801589868 @default.
• W2906596328 doi "https://doi.org/10.1007/5584_2018_305" @default.
• W2906596328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30569414" @default.
• W2906596328 hasPublicationYear "2018" @default.
• W2906596328 type Work @default.
• W2906596328 sameAs 2906596328 @default.
• W2906596328 citedByCount "29" @default.
• W2906596328 countsByYear W29065963282019 @default.
• W2906596328 countsByYear W29065963282020 @default.
• W2906596328 countsByYear W29065963282021 @default.
• W2906596328 countsByYear W29065963282022 @default.
• W2906596328 countsByYear W29065963282023 @default.
• W2906596328 crossrefType "book-chapter" @default.
• W2906596328 hasAuthorship W2906596328A5015316572 @default.
• W2906596328 hasAuthorship W2906596328A5067408895 @default.
• W2906596328 hasConcept C104317684 @default.
• W2906596328 hasConcept C107459253 @default.
• W2906596328 hasConcept C126322002 @default.
• W2906596328 hasConcept C145103041 @default.
• W2906596328 hasConcept C1491633281 @default.
• W2906596328 hasConcept C203014093 @default.
• W2906596328 hasConcept C207701140 @default.
• W2906596328 hasConcept C28328180 @default.
• W2906596328 hasConcept C2911091166 @default.
• W2906596328 hasConcept C502942594 @default.
• W2906596328 hasConcept C54355233 @default.
• W2906596328 hasConcept C71924100 @default.
• W2906596328 hasConcept C77255625 @default.
• W2906596328 hasConcept C86803240 @default.
• W2906596328 hasConcept C95444343 @default.
• W2906596328 hasConceptScore W2906596328C104317684 @default.
• W2906596328 hasConceptScore W2906596328C107459253 @default.
• W2906596328 hasConceptScore W2906596328C126322002 @default.
• W2906596328 hasConceptScore W2906596328C145103041 @default.
• W2906596328 hasConceptScore W2906596328C1491633281 @default.
• W2906596328 hasConceptScore W2906596328C203014093 @default.
• W2906596328 hasConceptScore W2906596328C207701140 @default.
• W2906596328 hasConceptScore W2906596328C28328180 @default.
• W2906596328 hasConceptScore W2906596328C2911091166 @default.
• W2906596328 hasConceptScore W2906596328C502942594 @default.
• W2906596328 hasConceptScore W2906596328C54355233 @default.
• W2906596328 hasConceptScore W2906596328C71924100 @default.
• W2906596328 hasConceptScore W2906596328C77255625 @default.
• W2906596328 hasConceptScore W2906596328C86803240 @default.
• W2906596328 hasConceptScore W2906596328C95444343 @default.
• W2906596328 hasLocation W29065963281 @default.
• W2906596328 hasLocation W29065963282 @default.
• W2906596328 hasOpenAccess W2906596328 @default.
• W2906596328 hasPrimaryLocation W29065963281 @default.
• W2906596328 hasRelatedWork W1888433033 @default.
• W2906596328 hasRelatedWork W2392750004 @default.
• W2906596328 hasRelatedWork W2415743749 @default.
• W2906596328 hasRelatedWork W2418603484 @default.
• W2906596328 hasRelatedWork W2479215566 @default.
• W2906596328 hasRelatedWork W2744405843 @default.

• next